SCHEMBL18178249

SCHEMBL18178249

COC(=O)Oc1cccc(C)c1COc1cc(Cl)c(C)cc1F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.39
SLC22A12 Q96S37 1/20 0.39
KDM4E B2RXH2 2/20 0.38
RAB9A P51151 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
ALDH1A1 P00352 2/20 0.38
NPC1 O15118 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
MAPT P10636 2/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
SGMS2 Q8NHU3 2/20 0.38
MRGPRX4 Q96LA9 3/20 0.37
HPGD P15428 1/20 0.37
HSD17B10 Q99714 1/20 0.37
AKR1C3 P42330 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
HTT P42858 1/20 0.36
POLB P06746 1/20 0.36
MAPK1 P28482 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18178242 0.93 SGMS2 (0.41) LMNAKDM4ERAB9ASMN1; SMN2ALDH1A1
SCHEMBL18178243 0.93 SGMS2 (0.41) LMNAKDM4ERAB9ASMN1; SMN2ALDH1A1
SCHEMBL18178344 0.91 SLC22A12 (0.41) LMNASLC22A12KDM4ERAB9AALDH1A1
SCHEMBL18178245 0.90 LMNA (0.37) LMNAKDM4ERAB9ASMN1; SMN2ALDH1A1
SCHEMBL18178250 0.90 MRGPRX4 (0.39) LMNAKDM4ERAB9ASMN1; SMN2ALDH1A1
SCHEMBL18178251 0.90 LMNA (0.41) LMNAKDM4ERAB9ASMN1; SMN2ALDH1A1
SCHEMBL18178246 0.90 LMNA (0.39) LMNAKDM4ERAB9ASMN1; SMN2ALDH1A1
SCHEMBL18182181 0.90 MRGPRX4 (0.37) LMNASLC22A12KDM4ERAB9AALDH1A1
SCHEMBL18178278 0.90 SLC22A12 (0.43) LMNASLC22A12KDM4ERAB9ASMN1; SMN2
SCHEMBL18178258 0.90 SLC22A12 (0.41) LMNASLC22A12KDM4ERAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9573904-B2 Aromatic compound and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-02-21 US disclosed
US-20160311775-A1 AROMATIC COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160311775-A1 AROMATIC COMPOUND AND USE THEREOF ZCCHC8, CBR3, CBX8 LMNA 4171/4885SLC22A12 4500/4885KDM4E 2107/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.